PF-05082566: Phase Ib data

Top-line data from 23 evaluable patients with advanced solid tumors in an open-label, U.S. Phase Ib trial showed that

Read the full 197 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE